Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TCF12 is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. Additionally we are shipping TCF12 Proteins (7) and many more products for this protein.
Showing 10 out of 92 products:
Human Polyclonal TCF12 Primary Antibody for IF (p), IHC (p) - ABIN1385824
Li, Leng, Liu, Hu, Zhang, Li, Jiang, Zhou, Xu: Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma. in Tumour biology 2017
Cow (Bovine) Polyclonal TCF12 Primary Antibody for WB - ABIN2780487
Lazrek, Goffard, Schanen, Karquel, Bocket, Lion, Devaux, Hedouin, Gosset, Hober: Detection of hepatitis C virus antibodies and RNA among medicolegal autopsy cases in Northern France. in Diagnostic microbiology and infectious disease 2006
Show all 2 Pubmed References
HDAC1 (show HDAC1 Antibodies) promoted migration and invasion of gallbladder tumor cells by binding with TCF12 to promote epithelial mesenchymal transformation.
Study describes the identification of three large inherited intragenic exon deletions in TCF12 using whole-genome sequencing and one large inherited duplication using targeted TCF12 sequencing in patients with craniosynostosis.
Heb expression is regulated by Med19 (show MED19 Antibodies) in breast cancer cells.
enforced expression of transcription factor 12 suppressed cell proliferation, migration, and invasion in vitro and inhibited tumor growth in vivo. In conclusion, transcription factor 12 protein may be a novel molecule which plays a critical role in prostate cancer progression and patients' prognosis, suggesting it might be a promising therapeutic target for prostate cancer therapy
HEB may be involved in GBM cell proliferation, as HEB silencing reduced proliferation in cells cultured as monolayers or neurospheres. Furthermore, the results suggested a potential role for HEB in the maintenance of GBM stem cells, as HEB silencing affected the differentiation capacity of cells.
Two novel translocations leading to the inactivation of RUNX1 (show RUNX1 Antibodies) and its partners SIN3A (show SIN3A Antibodies) and TCF12 in myeloid leukemia (show BCL11A Antibodies).
Studies suggest that transcription factor 12 (TCF12) should be included in level 2 genetic testing.
show that these mutations compromise TCF12 transcriptional activity and are associated with a more aggressive tumour type
several familial cases of coronal synostosis associated with mutations in TCF12
In t(8;21) leukemia cells, the two E proteins, HEB and E2A (show TCF3 Antibodies), function as components of the stable AML1 (show RUNX1 Antibodies)-ETO (show RUNX1T1 Antibodies)-containing transcription factor complex (AETFC). The AETFC components cooperatively regulate gene expression and contribute to leukemogenesis.
Tcf12 is a transcription factor highly expressed in the nuclei of stem cells and its downregulation plays an essential role in osteoblast differentiation.
we identified transcription factor TCF12 as a new target of miR (show MLXIP Antibodies)-211 in oral squamous cell carcinoma
HEB (show FREM1 Antibodies) is a fundamental link between Nodal signalling, the derepression of a specific class of poised promoters during differentiation, and lineage specification in mouse embryonic stem cells
severe bilateral coronal synostosis occurs in mice with 50% of the wild-type dosage of both the Tcf12 and Twist1 (show TWIST1 Antibodies) genes highlights the key role of TCF12 acting with TWIST1 (show TWIST1 Antibodies) in the normal development of the coronal sutures
Deficiency in the E proteins, E2A (show TCF3 Antibodies) and HEB (show FREM1 Antibodies), led to increased frequency of terminally differentiated effector KLRG1 (show KLRG1 Antibodies)(hi) CD8 (show CD8A Antibodies)(+) T cells in mice during infection, and decreased generation of longer-lived memory-precursor cells during the immune response.
Deletion of HEB (show FREM1 Antibodies) and E2A (show TCF3 Antibodies) in DP thymocytes specifically blocked the development of CD4 (show CD4 Antibodies)(+) lineage T cells. Furthermore, deletion of the E protein inhibitors Id2 and Id3 (show ID3 Antibodies) allowed CD4 (show CD4 Antibodies)(+) T cell development but blocked CD8 (show CD8A Antibodies)(+) lineage development.
the earliest event in B-cell specification involves the induction of FOXO1 (show FOXO1 Antibodies) expression and requires the combined activities of E2A (show TCF3 Antibodies) and HEB (show FREM1 Antibodies)
These results showed a new set of interactions between HEB (show FREM1 Antibodies), Notch1 (show NOTCH1 Antibodies), and GATA3 (show GATA3 Antibodies) that regulate the T-cell fate choice in developing thymocytes.
Developmental progression of fetal HEB (show FREM1 Antibodies)(-/-) precursors to the pre-T-cell stage is restored by HEBAlt.
HEB (show FREM1 Antibodies) is a specific and essential factor in T-cell development and in the generation of the iNKT cell lineage.
The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.
transcription factor 12
, transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)
, DNA-binding protein HTF4
, E-box-binding protein
, class B basic helix-loop-helix protein 20
, helix-loop-helix transcription factor 4
, transcription factor HTF-4
, class A helix-loop-helix transcription factor ME1
, SCBP alpha
, salivary-specific cAMP response element-binding protein alpha
, basic helix-loop-helix protein
, class A helix-loop-helix transcription factor GE1